Day 2 Program

Rapid Fire 3

Day 2: December 9, 2026

4:30 PM–5:30 PM CST

Stars at Night 1-2

Session Details

Moderator

Ana Christina Garrido-Castro, Dana-Farber Cancer Institute, Boston, MA

Moderator

Alessandra Gennari

RF3-1

Clinical validation of a multimodal model for frontline therapeutic selection in breast cancer

Luca Boscolo-Bielo, Memorial Sloan Kettering Cancer Center, New York, NY

RF3-2

A single cell and spatial atlas of preinvasive breast cancer

Aatish Thennavan, UT MD Anderson Cancer Center, Houston, TX

RF3-3

A Multi-cohort Comparison of Genomic, Clinical, and AI Models for Recurrence Prediction in Early Breast Cancer

Lajos Pusztai, Yale University, New Haven, CT

RF3-4

Validation of Quantitative Standardized High Sensitivity (HS)-HER2 as a prognostic factor for outcomes with trastuzumab deruxtecan (T-DXd) for metastatic breast cancer

Paolo Tarantino, Dana-Farber Cancer Institute, Boston, MA

RF3-5

Pretreatment spatial transcriptomic features associated with response to neoadjuvant HER2-targeted therapy in HER2-positive breast cancer

Emilia Morales, Karolinska Institutet, Stockholm, Sweden

RF3-6

Artera Multimodal AI Digital Pathology Identifies Distant Metastasis and Late Recurrence Risk Beyond the Recurrence Score: External Validation in TAILORx

Rima Patel, Icahn School of Medicine at Mount Sinai, New York, NY